{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T15:21:08Z","timestamp":1790176868342,"version":"4.1.0"},"reference-count":13,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,2,6]],"date-time":"2018-02-06T00:00:00Z","timestamp":1517875200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2018,2,6]],"date-time":"2018-02-06T00:00:00Z","timestamp":1517875200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Dominant optic atrophy (DOA) is a rare progressive and irreversible blinding disease which is one of the most frequent forms of hereditary optic neuropathy. DOA is mainly caused by dominant mutation in the <jats:italic>OPA1<\/jats:italic> gene encoding a large mitochondrial GTPase with crucial roles in membrane dynamics and cell survival. Hereditary optic neuropathies are commonly characterized by the degeneration of retinal ganglion cells, leading to the optic nerve atrophy and the progressive loss of visual acuity. Up to now, despite increasing advances in the understanding of the pathological mechanisms, DOA remains intractable. Here, we tested the efficiency of gene therapy on a genetically-modified mouse model reproducing DOA vision loss. We performed intravitreal injections of an Adeno-Associated Virus carrying the human <jats:italic>OPA1<\/jats:italic> cDNA under the control of the cytomegalovirus promotor. Our results provide the first evidence that gene therapy is efficient on a mouse model of DOA as the wild-type <jats:italic>OPA1<\/jats:italic> expression is able to alleviate the <jats:italic>OPA1<\/jats:italic>-induced retinal ganglion cell degeneration, the hallmark of the disease. These results displayed encouraging effects of gene therapy for Dominant Optic Atrophy, fostering future investigations aiming at clinical trials in patients.<\/jats:p>","DOI":"10.1038\/s41598-018-20838-8","type":"journal-article","created":{"date-parts":[[2018,1,31]],"date-time":"2018-01-31T10:18:00Z","timestamp":1517393880000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":76,"title":["OPA1 gene therapy prevents retinal ganglion cell loss in a Dominant Optic Atrophy mouse model"],"prefix":"10.1038","volume":"8","author":[{"given":"Emmanuelle","family":"Sarzi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Seveno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camille","family":"Piro-M\u00e9gy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucie","family":"Elzi\u00e8re","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00e9lanie","family":"Quil\u00e8s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"P\u00e9quignot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agn\u00e8s","family":"M\u00fcller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian P.","family":"Hamel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guy","family":"Lenaers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9cile","family":"Delettre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,2,6]]},"reference":[{"key":"20838_CR1","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1136\/jmg.2007.054270","volume":"46","author":"P Yu-Wai-Man","year":"2009","unstructured":"Yu-Wai-Man, P., Griffiths, P. G., Hudson, G. & Chinnery, P. F. Inherited mitochondrial optic neuropathies. Journal of medical genetics 46, 145\u2013158, https:\/\/doi.org\/10.1136\/jmg.2007.054270 (2009).","journal-title":"Journal of medical genetics"},{"key":"20838_CR2","doi-asserted-by":"publisher","first-page":"R12","DOI":"10.1093\/hmg\/ddx182","volume":"26","author":"P Yu-Wai-Man","year":"2017","unstructured":"Yu-Wai-Man, P. & Newman, N. J. Inherited eye-related disorders due to mitochondrial dysfunction. Human molecular genetics 26, R12\u2013R20, https:\/\/doi.org\/10.1093\/hmg\/ddx182 (2017).","journal-title":"Human molecular genetics"},{"key":"20838_CR3","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1038\/79936","volume":"26","author":"C Delettre","year":"2000","unstructured":"Delettre, C. et al. Nuclear gene OPA1, encoding a mitochondrial dynamin-related protein, is mutated in dominant optic atrophy. Nat Genet 26, 207\u2013210, https:\/\/doi.org\/10.1038\/79936 (2000).","journal-title":"Nat Genet"},{"key":"20838_CR4","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.preteyeres.2010.11.002","volume":"30","author":"P Yu-Wai-Man","year":"2011","unstructured":"Yu-Wai-Man, P., Griffiths, P. G. & Chinnery, P. F. Mitochondrial optic neuropathies - disease mechanisms and therapeutic strategies. Progress in retinal and eye research 30, 81\u2013114, https:\/\/doi.org\/10.1016\/j.preteyeres.2010.11.002 (2011).","journal-title":"Progress in retinal and eye research"},{"key":"20838_CR5","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1055\/s-0035-1563574","volume":"35","author":"P Yu-Wai-Man","year":"2015","unstructured":"Yu-Wai-Man, P. Therapeutic Approaches to Inherited Optic Neuropathies. Semin Neurol 35, 578\u2013586, https:\/\/doi.org\/10.1055\/s-0035-1563574 (2015).","journal-title":"Semin Neurol"},{"key":"20838_CR6","doi-asserted-by":"publisher","first-page":"3599","DOI":"10.1093\/brain\/aws303","volume":"135","author":"E Sarzi","year":"2012","unstructured":"Sarzi, E. et al. The human OPA1delTTAG mutation induces premature age-related systemic neurodegeneration in mouse. Brain: a journal of neurology 135, 3599\u20133613, https:\/\/doi.org\/10.1093\/brain\/aws303 (2012).","journal-title":"Brain: a journal of neurology"},{"key":"20838_CR7","doi-asserted-by":"publisher","first-page":"2539","DOI":"10.1093\/hmg\/ddw117","volume":"25","author":"E Sarzi","year":"2016","unstructured":"Sarzi, E. et al. Increased steroidogenesis promotes early-onset and severe vision loss in females with OPA1 dominant optic atrophy. Human molecular genetics 25, 2539\u20132551, https:\/\/doi.org\/10.1093\/hmg\/ddw117 (2016).","journal-title":"Human molecular genetics"},{"key":"20838_CR8","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/S0079-6123(09)17510-6","volume":"175","author":"AR Harvey","year":"2009","unstructured":"Harvey, A. R., Hellstrom, M. & Rodger, J. Gene therapy and transplantation in the retinofugal pathway. Progress in brain research 175, 151\u2013161, https:\/\/doi.org\/10.1016\/S0079-6123(09)17510-6 (2009).","journal-title":"Progress in brain research"},{"key":"20838_CR9","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.exer.2015.05.008","volume":"141","author":"V Porciatti","year":"2015","unstructured":"Porciatti, V. Electrophysiological assessment of retinal ganglion cell function. Experimental eye research 141, 164\u2013170, https:\/\/doi.org\/10.1016\/j.exer.2015.05.008 (2015).","journal-title":"Experimental eye research"},{"key":"20838_CR10","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1089\/hum.2016.040","volume":"27","author":"L Petit","year":"2016","unstructured":"Petit, L., Khanna, H. & Punzo, C. Advances in Gene Therapy for Diseases of the Eye. Human gene therapy 27, 563\u2013579, https:\/\/doi.org\/10.1089\/hum.2016.040 (2016).","journal-title":"Human gene therapy"},{"key":"20838_CR11","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1017\/S0952523898151118","volume":"15","author":"MW Hankins","year":"1998","unstructured":"Hankins, M. W., Jones, R. J. & Ruddock, K. H. Diurnal variation in the b-wave implicit time of the human electroretinogram. Vis Neurosci 15, 55\u201367 (1998).","journal-title":"Vis Neurosci"},{"key":"20838_CR12","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1159\/000321118","volume":"45","author":"K Chekroud","year":"2011","unstructured":"Chekroud, K. et al. Simple and efficient: validation of a cotton wick electrode for animal electroretinography. Ophthalmic Res 45, 174\u2013179, https:\/\/doi.org\/10.1159\/000321118 (2011).","journal-title":"Ophthalmic Res"},{"key":"20838_CR13","doi-asserted-by":"publisher","first-page":"4611","DOI":"10.1167\/iovs.04-0541","volume":"45","author":"GT Prusky","year":"2004","unstructured":"Prusky, G. T., Alam, N. M., Beekman, S. & Douglas, R. M. Rapid quantification of adult and developing mouse spatial vision using a virtual optomotor system. Investigative ophthalmology & visual science 45, 4611\u20134616, https:\/\/doi.org\/10.1167\/iovs.04-0541 (2004).","journal-title":"Investigative ophthalmology & visual science"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-20838-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-20838-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-20838-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,21]],"date-time":"2022-12-21T02:07:30Z","timestamp":1671588450000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-20838-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2,6]]},"references-count":13,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,12]]}},"alternative-id":["20838"],"URL":"https:\/\/doi.org\/10.1038\/s41598-018-20838-8","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,2,6]]},"assertion":[{"value":"23 August 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 January 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 February 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"2468"}}